Module information
Details
- Title
- Presentation and Management of Bronchiectasis
- Type
- Stage Two
- Module code
- HPS161
- Requirement
- Compulsory
Module objective
By the end of this module the Clinical Scientist in HSST, with respect to the presentation and management of patients with stable bronchiectasis, will be able to analyse, synthesise, evaluate and apply their knowledge, to be competent to carry out specialist assessment and leading to appropriate and effective management, within the scope of a Consultant Clinical Scientist.
Knowledge and understanding
By the end of this module the Clinical Scientist in HSST will analyse, synthesise, evaluate and critically apply their expert knowledge with respect to:
- the causes of bronchiectasis.
- limited relevant Microbiology.
- the investigation of bronchiectasis.
- the differential diagnosis of bronchiectasis.
- the treatment and management of patients with stable bronchiectasis, in conjunction with clinical colleagues, including the role of physiotherapy.
- the pharmacology of common drugs used including role of nebulised antibiotic therapy (see associated clinical skills.)
- the relevant guidelines.
Technical and clinical skills
By the end of this module the Clinical Scientist in HSST will be expected to critically reflect and apply in practice a range of clinical and communication skills to advise and communicate effectively with patients with stable bronchiectasis, relevant clinicians, patients and the public and other healthcare professionals and will:
- use inhaled and nebulised drug therapy.
- interpret appropriate Lung Function Tests
- non-invasive ventilation (see associated clinical skills).
Attitudes and behaviours
By the end of this module the Clinical Scientist in HSST will be expected to evaluate their own response to both normal and complex situations demonstrating the professional attributes and insights required of a Consultant Clinical Scientist working within the limits of professional competence referring as appropriate to senior staff and will:
- involve patient in management decisions, particularly with regard to risk/benefit issues of treatment in conjunction with clinical colleagues and “ceiling of care” apropos mechanical ventilation.
- inform patient, where appropriate, of prognosis and the requirement for clinician support.
- support the patient/carer in poorer prognosis disease.
- work to relieve symptoms where disease course cannot be beneficially affected and the requirement for clinician support.
- recognise the possible role for palliative care team.
- recognise the role for an MDT approach to management.